PHARMANUTRA SPA (PHN.MI) Stock Price & Overview
BIT:PHN • IT0005274094
Current stock price
The current stock price of PHN.MI is 78.6 EUR. Today PHN.MI is down by 0%. In the past month the price increased by 17.14%. In the past year, price increased by 61.9%.
PHN.MI Key Statistics
- Market Cap
- 760.848M
- P/E
- 59.10
- Fwd P/E
- 38.78
- EPS (TTM)
- 1.33
- Dividend Yield
- 1.27%
PHN.MI Stock Performance
PHN.MI Stock Chart
PHN.MI Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to PHN.MI. When comparing the yearly performance of all stocks, PHN.MI is one of the better performing stocks in the market, outperforming 89% of all stocks.
PHN.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to PHN.MI. PHN.MI gets an excellent profitability rating and is at the same time showing great financial health properties.
PHN.MI Earnings
On March 17, 2026 PHN.MI reported an EPS of 0.63 and a revenue of 37.08M. The company beat EPS expectations (0.61% surprise) and beat revenue expectations (0.59% surprise).
PHN.MI Forecast & Estimates
7 analysts have analysed PHN.MI and the average price target is 88.74 EUR. This implies a price increase of 12.9% is expected in the next year compared to the current price of 78.6.
For the next year, analysts expect an EPS growth of 43.02% and a revenue growth 15.93% for PHN.MI
PHN.MI Groups
Sector & Classification
PHN.MI Financial Highlights
Over the last trailing twelve months PHN.MI reported a non-GAAP Earnings per Share(EPS) of 1.33. The EPS decreased by -14.74% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 13.39% | ||
| ROA | 20.17% | ||
| ROE | 36.55% | ||
| Debt/Equity | 0.24 |
PHN.MI Ownership
PHN.MI Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LOR | L'OREAL | 25.68 | 191.6B | ||
| OR | L'OREAL | 25.68 | 191.574B | ||
| BEI | BEIERSDORF AG | 16.78 | 18.298B | ||
| ITP | INTERPARFUMS SA | 16.64 | 2.003B | ||
| ICOS | INTERCOS SPA | 16 | 1.174B | ||
| ONTEX | ONTEX GROUP NV | 4.31 | 244.168M | ||
| ENV | ENERVIT | 15.06 | 78.498M | ||
| JBOG | JACQUES BOGART | N/A | 47.07M |
Related stock screener links
View all stocks in the Personal Care Products Industry | View all stocks in the Consumer Staples Sector | View all stocks on the Euronext Milan Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find more growth stocks the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About PHN.MI
Company Profile
Pharmanutra SpA develops nutraceutical products and medical devices. The company is headquartered in Pisa, Pisa. The company went IPO on 2017-07-18. The firm develops nutraceutical products and medical devices. The company focuses on studying and producing formulations that are backed up in scientific research. The company is able to cover all stages of the development of a product, from its design, formulation and registration to its marketing, distribution and training of its commercial representatives. The firm offers Gestalys DHA, a nutritional supplement; Cetilar, a massage coadiuvant, improves and brings relief to joints affected by osteoarthritis; Cetilar patch, a transdermic patch containing a concentrated formulation of cetylated fatty acids (CFA) esters; SiderAL Forte; CardioSiderAL; SiderAL Folico; SiderAL; Bonecal and Novomega, among others.
Company Info
IPO: 2017-07-18
PHARMANUTRA SPA
Via delle Lenze n. 216/B
Pisa PISA IT
Employees: 128
Phone: 390507846500
PHARMANUTRA SPA / PHN.MI FAQ
What does PHN do?
Pharmanutra SpA develops nutraceutical products and medical devices. The company is headquartered in Pisa, Pisa. The company went IPO on 2017-07-18. The firm develops nutraceutical products and medical devices. The company focuses on studying and producing formulations that are backed up in scientific research. The company is able to cover all stages of the development of a product, from its design, formulation and registration to its marketing, distribution and training of its commercial representatives. The firm offers Gestalys DHA, a nutritional supplement; Cetilar, a massage coadiuvant, improves and brings relief to joints affected by osteoarthritis; Cetilar patch, a transdermic patch containing a concentrated formulation of cetylated fatty acids (CFA) esters; SiderAL Forte; CardioSiderAL; SiderAL Folico; SiderAL; Bonecal and Novomega, among others.
What is the stock price of PHARMANUTRA SPA today?
The current stock price of PHN.MI is 78.6 EUR.
What is the dividend status of PHARMANUTRA SPA?
PHARMANUTRA SPA (PHN.MI) has a dividend yield of 1.27%. The yearly dividend amount is currently 0.85.
What is the ChartMill technical and fundamental rating of PHN stock?
PHN.MI has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
On which exchange is PHN.MI stock listed?
PHN.MI stock is listed on the Euronext Milan exchange.
Should I buy PHN stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on PHN.MI.